Funds and ETFs Recordati

Equities

REC

IT0003828271

Pharmaceuticals

Market Closed - Borsa Italiana 16:44:59 26/04/2024 BST 5-day change 1st Jan Change
49.1 EUR +0.61% Intraday chart for Recordati -1.52% +0.55%

ETFs positioned on Recordati

Name Weight AuM 1st Jan change Investor Rating
1.52% 5 M€ +12.55%
0.42% 2 M€ +7.72%
0.32% 182 M€ +6.98%
0.29% 3 M€ +9.95% -
0.24% 1,120 M€ +0.40%
0.20% 18 M€ +3.79% -
0.06% 6 M€ -.--% -
0.06% 31 M€ +3.50% -
0.04% 6 M€ -.--%
0.03% 10 M€ -3.35% -
0.01% 284 M€ -.--%
0.01% 206 M€ -.--%
0.01% 23 M€ -.--% -
0.01% 786 M€ -.--%
0.01% 273 M€ +15.83%
0.01% 607 M€ +0.05% -
0.01% 1,166 M€ +0.26% -
0.01% 389 M€ +6.83% -
0.00% 34 M€ +6.71% -
0.00% 7 M€ +0.11% -
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (32.1%). Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.1 EUR
Average target price
52.14 EUR
Spread / Average Target
+6.19%
Consensus
  1. Stock Market
  2. Equities
  3. REC Stock
  4. Funds and ETFs Recordati